Tarsus Pharmaceuticals, Inc. (TARS)
71.42
-1.39
(-1.91%)
USD |
NASDAQ |
Aug 25, 15:13
Tarsus Pharmaceuticals Total Assets (Quarterly) : 611.14M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 611.14M |
| March 31, 2026 | 581.14M |
| December 31, 2025 | 566.90M |
| September 30, 2025 | 534.56M |
| June 30, 2025 | 494.99M |
| March 31, 2025 | 500.75M |
| December 31, 2024 | 377.34M |
| September 30, 2024 | 376.30M |
| June 30, 2024 | 376.84M |
| March 31, 2024 | 349.28M |
| December 31, 2023 | 266.22M |
| September 30, 2023 | 268.33M |
| June 30, 2023 | 188.93M |
| March 31, 2023 | 211.21M |
| Date | Value |
|---|---|
| December 31, 2022 | 227.86M |
| September 30, 2022 | 236.46M |
| June 30, 2022 | 252.83M |
| March 31, 2022 | 181.48M |
| December 31, 2021 | 178.91M |
| September 30, 2021 | 190.41M |
| June 30, 2021 | 203.45M |
| March 31, 2021 | 193.95M |
| December 31, 2020 | 171.97M |
| September 30, 2020 | 92.18M |
| June 30, 2020 | 56.24M |
| March 31, 2020 | |
| December 31, 2019 | 58.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Structure Therapeutics, Inc. | 1.425B |
| Alumis, Inc. | 560.62M |
| Veradermics, Inc. | 826.33M |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 264.41M |
| Shareholders Equity (Quarterly) | 346.73M |
| Debt to Equity Ratio | 0.2557 |
| Current Ratio | 3.198 |
| Net Debt Paydown Yield | -0.12% |